Free shipping on all orders over $ 500

 About 1 result found for searched term "184475-35-2" (0.127 seconds)

Cat.No.  Name Target
M1749 Gefitinib EGFR/HER2
ZD-1839, Iressa
Gefitinib (ZD1839) is an EGFR tyrosine kinase and Akt phosphorylation inhibitor. Gefitinib significantly down-regulates CD47 expression and increases DC phagocytosis in non-small cell lung cancer cells such as PC9, H1437 and H1573. Gefitinib combined with CD47 antibody can enhance the phagocytosis of macrophages.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.